Finance

Lists
Why is 8CC down 5,98%?
Dive Deeper
8CC:FRA
Cocrystal Pharma Inc
€0,86
-5,98%
(-0,055) 1D
5 Nov., 08:18:28 GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 8CC...
Open
€0,86
High
€0,86
Low
€0,86
Mkt. cap
19,46 m
Avg. vol.
15,00
Volume
0,00
52-wk high
€1,30
52-wk low
€0,69
No. of employees
10
Open
€0,86
High
€0,86
Low
€0,86
Mkt. cap
19,46 m
Avg. vol.
15,00
Volume
0,00
52-wk high
€1,30
52-wk low
€0,69
No. of employees
10
News stories
From web sources and news partners
About Cocrystal Pharma Inc
CEO-
Employees10
Founded2006
HeadquartersBothell, Washington, Verenigde State van Amerika
SectorPharmaceutical industry
Industry-
Websitecocrystalpharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
-
-
225,00 k
105,00 k
Cost of goods sold
954,00 k
1,62 m
1,37 m
2,14 m
Cost of revenue
954,00 k
1,62 m
1,37 m
2,14 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,14 m
862,00 k
1,21 m
1,15 m
Operating expense
1,14 m
862,00 k
1,21 m
1,15 m
Total operating expenses
2,09 m
2,48 m
2,58 m
3,29 m
Operating income
-2,09 m
-2,48 m
-2,36 m
-3,18 m
Other non operating income
-
-
-
-
EBT including unusual items
-2,05 m
-2,43 m
-2,30 m
-3,16 m
EBT excluding unusual items
-2,05 m
-2,43 m
-2,30 m
-3,16 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2,05 m
-2,43 m
-2,30 m
-3,16 m
Net profit margin
-
-
-1 021,78%
-3 013,33%
Earnings per share
-0,19
-0,17
-0,17
-0,23
Interest and investment income
22,00 k
47,00 k
22,00 k
10,00 k
Interest expense
-
-
-
-
Net interest expenses
22,00 k
47,00 k
22,00 k
10,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,08 m
-2,47 m
-2,34 m
-3,17 m
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme